The mission of the Chicago Biomedical Consortium (CBC) is to stimulate collaboration among scientists at Northwestern University, The University of Chicago, the University of Illinois at Chicago and others to accelerate discovery that will transform biomedical research and improve the health of humankind.
The CBC gratefully acknowledges support from the Searle Funds at The Chicago Community Trust.
Announcements

January 16, 2018
announcement
CBC is inviting new applications for the Catalyst Award program

One-time incentive awards (up to $250,000), focused on basic biological/biomedical or translational research, made to teams with principals and other strong representation from at least two of the CBC institutions.

If you plan to apply, please make sure that you are conforming to the MOST RECENT RFA revised Jan. 16, 2018. Applications not conforming to the specified guidelines will NOT be accepted.

Spring 2018 round submissions open at 8:00 AM on February 19, 2018 and close at 5:00 PM on February 23, 2018.

▸ CBC Catalyst Award RFA, rev. Jan. 16, 2018


▸ More Announcements

CBC on Twitter
News

February 22, 2018
NEWS
Fall 2017 Round Catalyst Awards Announced

The CBC is pleased to announce that three teams received Catalyst Awards in Fall 2017 application round:

PIs: Yamuna Krishnan (UChicago) and Dimitri Krainc (NU) for the project: In situ Lysosomal Ion Imaging as a Sensitive Diagnostic for Lysosomal Disorders

PIs: Raymond Moellering (UChicago) and Sarki Abdulkadir (NU) for the project: Defining Prostate Tumor Malignancy with Activity-Dependent Pet Probes

PIs: Xiaojing Yang (UIC) and Minglei Zhao (UChicago) for the project: Observing Protein Allostery Dynamics by Single-Particle Imaging

▸ Read more


February 22, 2018
SUCCESS STORY
What causes one disease may cure another—two NU scientists and CBC community members, Marcus Peter and Shad Thaxton, collaborate to develop a potent cancer treatment

Marcus Peter and Shad Thaxton, NU, are senior authors on a recent publication in EMBO Reports, that describes how small interfering RNAs (siRNAs) with high homology to the trinucleotide repeat expansions of the huntingtin gene (responsible for Huntington’s disease), are highly toxic to cancer cells both in culture and in animal models. The authors suggest that such siRNAs could be exploited to develop novel anti-cancer reagents. Both scientists have links to CBC: Peter was an invited speaker at a 2013 CBC Exploratory Workshop, focused to ovarian cancer. Thaxton and a postdoc in his lab, Linda Foid, received a 2014 CBC Postdoctoral Research Award. Congratulations!

▸ Read more


February 14, 2018
SUCCESS STORY
Tricking bacteria to remain non-hostile may become a method of choice in preventive medicine—the Federle lab at UIC shows how

A recent publication from the Federle lab, UIC, published in the Journal of Biological Chemistry, describes a novel compound able to induce quorum sensing (QS)—the process of regulation of gene expression in response to fluctuations in bacteria density. Learning how to perturb QS in a density-independent way presents an intriguing possibility of regulating bacterial virulence. The study is partially attributed to CBC funding via a CBC High-throughput Screening Award (2015) to Michael Federle (UIC) and Tiara Pérez Morales (currently at Benedictine University). Pérez Morales is first, and Federle senior author on the paper. Kiira Ratia, UIC is one of the co-authors. Federle and Ratia have many additional links to CBC (see the article). Congratulations to all involved in the study!

▸ Read more


▸ More News
 

DIRECTOR’S CORNER

February 23, 2018
Director’s Corner
Evolving FDA guidance for developing early Alzheimer’s Disease therapeutics

Earlier this month (Feb. 2018), FDA published draft guidance representing their evolving position on the development of therapeutics for the early stages of Alzheimer’s Disease (AD). The guidance document is relatively concise (only 7 pages) and I think should be required reading for those involved in any component of the AD/neurodegeneration drug discovery/development endeavor.
Jim Audia

▸ Read More


▸ More Posts

Featured Events

April 11, 2018
UChicago Department of Neurobiology
The 2018 Carlson Symposium on Neuroscience: Motor Circuits in Health and Disease


April 25-26, 2018
UChicago Computation Institute
GlobusWorld 2018: Connecting your Research Universe


May 10, 2018
NU Cognitive Neurology and Alzheimer’s Disease Center
24th Annual Alzheimer Day


May 16, 2018
UChicago Computation Institute
Future Compute: A Celebration of the Computation Institute


▸ More Events

Biotech & Entrepreneurship

March 20, 2018
SmartHealth Activator & Rosalind Franklin University of Medicine and Science
BioPathways Entrepreneurial Speaker Series

BioPathways: Fast-tracking Drug Repurposing for New Treatments of Life-threatening Diseases; Featuring Dr. Bruce Bloom, CEO, Cures Within Reach
▸ More info and registration details
(flyer)


▸ More Biotech & Entrepreneurship News